2024. Intravenous Tocilizumab versus Standard of Care in the Treatment of Severe and Critical COVID-19-related Pneumonia: A Single Center, Double-blind, Placebo Controlled, Phase 3 Trial . Acta Medica Philippina. 58, 6 (Apr. 2024). DOI:https://doi.org/10.47895/amp.vi0.6175.